Contracts Finder · Tender

GB-Salisbury: BDF Phase 2

A public procurement published by DSTL via Contracts Finder.

Contracts FinderTender
Award value
£113k
Tender value
0
Suppliers
0
Awards
1
Notices
Tender
Stage

Overview

Research towards a biosurveillance (BSV) system, is required by MoD. It will aim to provide early warning, situational awareness and forecasting of disease activity in an operational context. Outbreaks may be caused by naturally occurring infections, accidental contamination or deliberate biological attacks. A BSV capability will need to fuse data from disparate military and civilian sources, to provide decision-makers with a comprehensive daily picture of disease activity within an Area of Interest (AOI). The aim of this work is to further develop and demonstrate a working prototype BSV data fusion method, utilising simulated data based on currently available data sources, a…

Key details

Buyer
DSTL
Source
Contracts Finder
Lifecycle stage
Tender
Status
active
CPV classification
73100000 — Research and experimental development services
Currency
GBP
Total award value
Tender value
£113,000
First published
10 Mar 2017
Last updated
10 Mar 2017
View the original notice

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Tender noticeGB-Salisbury: BDF Phase 2

Frameworks & programmes

More from DSTL

FAQs about this procurement

Who is the buyer for "GB-Salisbury: BDF Phase 2"?

GB-Salisbury: BDF Phase 2 is a UK public-sector procurement published by DSTL via Contracts Finder.

Has "GB-Salisbury: BDF Phase 2" been awarded?

No award has been recorded yet. The current lifecycle stage is "Tender".

What is "GB-Salisbury: BDF Phase 2" worth?

The reported tender value is £113,000.

When was "GB-Salisbury: BDF Phase 2" published?

It was first published on 10 Mar 2017 and last updated on 10 Mar 2017, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable